vaxfectin and Myalgia

vaxfectin has been researched along with Myalgia* in 1 studies

Trials

1 trial(s) available for vaxfectin and Myalgia

Article	Year
Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial. The American journal of tropical medicine and hygiene, 2018, Volume: 98, Issue:3 We conducted an open label, dose escalation Phase 1 clinical trial of a tetravalent dengue DNA vaccine (TVDV) formulated in Vaxfectin Topics: Adjuvants, Immunologic; Adult; Antibodies, Neutralizing; Antibodies, Viral; Dengue; Dengue Vaccines; Dengue Virus; Fatigue; Female; Headache; Humans; Immunity, Cellular; Immunization Schedule; Immunogenicity, Vaccine; Injections, Intramuscular; Interferon-gamma; Male; Myalgia; Patient Safety; Phosphatidylethanolamines; Vaccination; Vaccines, DNA	2018

Article

Year

Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial.

The American journal of tropical medicine and hygiene, 2018, Volume: 98, Issue:3

We conducted an open label, dose escalation Phase 1 clinical trial of a tetravalent dengue DNA vaccine (TVDV) formulated in Vaxfectin

Topics: Adjuvants, Immunologic; Adult; Antibodies, Neutralizing; Antibodies, Viral; Dengue; Dengue Vaccines; Dengue Virus; Fatigue; Female; Headache; Humans; Immunity, Cellular; Immunization Schedule; Immunogenicity, Vaccine; Injections, Intramuscular; Interferon-gamma; Male; Myalgia; Patient Safety; Phosphatidylethanolamines; Vaccination; Vaccines, DNA

2018